MidWestOne Financial Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $307K | Sell |
3,926
-150
| -4% | -$11.7K | 0.04% | 247 |
|
|
2025
Q1 | $295K | Buy |
4,076
+150
| +4% | +$10.9K | 0.04% | 231 |
|
|
2024
Q4 | $291K | Sell |
3,926
-1,125
| -22% | -$83.3K | 0.04% | 245 |
|
|
2024
Q3 | $333K | Sell |
5,051
-15
| -0.3% | -$990 | 0.05% | 236 |
|
|
2024
Q2 | $468K | Buy |
5,066
+15
| +0.3% | +$1.39K | 0.08% | 209 |
|
|
2024
Q1 | $483K | Hold |
5,051
| – | – | 0.09% | 211 |
|
|
2023
Q4 | $385K | Buy |
5,051
+96
| +2% | +$7.32K | 0.07% | 220 |
|
|
2023
Q3 | $343K | Sell |
4,955
-1,212
| -20% | -$84K | 0.08% | 215 |
|
|
2023
Q2 | $582K | Buy |
6,167
+2,337
| +61% | +$220K | 0.13% | 190 |
|
|
2023
Q1 | $317K | Buy |
+3,830
| New | +$317K | 0.07% | 212 |
|
|
2022
Q3 | – | Sell |
-2,337
| Closed | -$222K | – | 231 |
|
|
2022
Q2 | $222K | Buy |
+2,337
| New | +$222K | 0.05% | 213 |
|
|
2021
Q4 | – | Sell |
-3,240
| Closed | -$367K | – | 247 |
|
|
2021
Q3 | $367K | Buy |
+3,240
| New | +$367K | 0.09% | 178 |
|
|
2020
Q2 | – | Sell |
-4,791
| Closed | -$301K | – | 146 |
|
|
2020
Q1 | $301K | Sell |
4,791
-426
| -8% | -$26.8K | 0.11% | 152 |
|
|
2019
Q4 | $405K | Sell |
5,217
-1,704
| -25% | -$132K | 0.08% | 170 |
|
|
2019
Q3 | $506K | Sell |
6,921
-15,441
| -69% | -$1.13M | 0.16% | 140 |
|
|
2019
Q2 | $1.38M | Buy |
+22,362
| New | +$1.38M | 0.38% | 58 |
|